227 related articles for article (PubMed ID: 16543070)
1. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation.
Ashizuka S; Peranteau WH; Hayashi S; Flake AW
Exp Hematol; 2006 Mar; 34(3):359-68. PubMed ID: 16543070
[TBL] [Abstract][Full Text] [Related]
2. Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model.
Shi C; Li Z; Sun Z; Pan L
Transplant Cell Ther; 2024 Apr; 30(4):398.e1-398.e10. PubMed ID: 38331194
[TBL] [Abstract][Full Text] [Related]
3. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation.
Peranteau WH; Hayashi S; Hsieh M; Shaaban AF; Flake AW
Blood; 2002 Sep; 100(6):2225-34. PubMed ID: 12200389
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
5. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
[TBL] [Abstract][Full Text] [Related]
6. Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.
Peake K; Manning J; Lewis CA; Barr C; Rossi F; Krieger C
J Vis Exp; 2015 Apr; (98):e52553. PubMed ID: 25867947
[TBL] [Abstract][Full Text] [Related]
7. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
Peranteau WH; Heaton TE; Gu YC; Volk SW; Bauer TR; Alcorn K; Tuschong LM; Johnson MP; Hickstein DD; Flake AW
Biol Blood Marrow Transplant; 2009 Mar; 15(3):293-305. PubMed ID: 19203720
[TBL] [Abstract][Full Text] [Related]
8. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
9. Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.
Peranteau WH; Hayashi S; Abdulmalik O; Chen Q; Merchant A; Asakura T; Flake AW
Blood; 2015 Sep; 126(10):1245-54. PubMed ID: 26124498
[TBL] [Abstract][Full Text] [Related]
10. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.
Peranteau WH; Endo M; Adibe OO; Merchant A; Zoltick PW; Flake AW
Blood; 2006 Dec; 108(13):4268-74. PubMed ID: 16954501
[TBL] [Abstract][Full Text] [Related]
11. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
12. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
13. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
[TBL] [Abstract][Full Text] [Related]
14. Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment.
Shaaban AF; Kim HB; Gaur L; Liechty KW; Flake AW
Exp Hematol; 2006 Sep; 34(9):1278-87. PubMed ID: 16939821
[TBL] [Abstract][Full Text] [Related]
15. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD
Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222
[TBL] [Abstract][Full Text] [Related]
16. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
18. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
Hayashi S; Peranteau WH; Shaaban AF; Flake AW
Blood; 2002 Aug; 100(3):804-12. PubMed ID: 12130490
[TBL] [Abstract][Full Text] [Related]
19. Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.
Shirasugi N; Emmanouilidis N; Pearson TC; Larsen CP
Transplant Proc; 2004 Oct; 36(8):2423-4. PubMed ID: 15561267
[TBL] [Abstract][Full Text] [Related]
20. A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model.
Dighe NM; Tan KW; Tan LG; Shaw SSW; Buckley SMK; Sandikin D; Johana N; Tan YW; Biswas A; Choolani M; Waddington SN; Antoniou MN; Chan JKY; Mattar CNZ
Exp Hematol; 2018 Jun; 62():45-55. PubMed ID: 29605545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
